Agenda
Join us on Tuesday, February 28th as we kick-off the conference with our Feeding the Pipeline series. You will hear discussions from leaders of five of the most productive research institutes in the US.
Agenda Coming Soon
2027 Conference Speakers
Srini Akkaraju, M.D., Ph.D.Founder & Managing PartnerSamsara BioCapital
Jamil BegPartnerSV Health Investors
Jeremy Caldwell, Ph.D.Managing DirectorRed Tree Venture Capital
Mira Chaurushiya, Ph.D.Managing DirectorWestlake Village BioPartners
Alex Cogdill, MEng, Ph.D.Head of Strategic Initiatives, Global Business DevelopmentDaiichi Sankyo U.S.
John Connolly, Ph.D.Chief Scientific OfficerParker Institute for Cancer Immunotherapy
Martin Crook, Ph.D.Vice President, Global Business DevelopmentDaiichi Sankyo
Richard DiMarchi, Ph.D.GLP-1 Biology Pioneer; Distinguished Professor, Indiana University
Jon Edwards, Ph.D.PartnerForbion
Rob Garbaccio, Ph.D.SVP, Worldwide Head of Search & Evaluation and Science StrategyMerck
Richard Glynne, Ph.D.Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture PartnerVersant Ventures
Jeffrey Golden, M.D.Director, Burns and Allen Research Institute & Executive Vice Dean for Research and EducationCedars Sinai Medical Center
Corey Goodman, Ph.D.Managing PartnervenBio Partners
Richard Heyman, Ph.D.Venture PartnerARCH Ventures
Tony HoChief Scientific Officer & Senior Science PartnerPivotal Life Sciences
Jeremy JenkinsUS Head Discovery SciencesNovartis
Rachna KhoslaSenior Vice President, Business DevelopmentAmgen
Deborah LawChief Scientific OfficerXaira Therapeutics
John Lepore, M.D.CEO, ProFound Therapeutics; CEO-PartnerFlagship Pioneering
Tim Luker, Ph.D.Vice President, Lilly Ventures, West Coast USA Head, Corp BDEli Lilly
Detlev Mennerich, Ph.D.Global HeadBoehringer Ingelheim Venture Fund
Grace Han McMahonAVP and Head, Pacific BD&LMerck
David MollerVenture PartnerThird Rock Ventures
Nikhil Mutyal, Ph.D.Head of Search & Evaluation, Respiratory & ImmunologyAstraZeneca
Deborah NguyenOperating PartnerRed Tree Venture Labs
Deborah Palestrant, Ph.D.Partner & Executive Chair, 4:59 Initiative5AM Ventures
Sunil PatelHead of Corporate Development and Business Development & LicensingMerck
Andy PlumpPresident, Research & DevelopmentTakeda Pharmaceutical Company Ltd.
Jeremy QuirkVP BD&L Commercial PortfolioGSK
John Reed, M.D., Ph.D.EVP, Pharmaceuticals, Research & DevelopmentJohnson & Johnson Innovative Medicine
Peter Schultz, Ph.D.President, CEO & Professor of ChemistryScripps Research
Avi Spier, Ph.D.Executive Director, Search & EvaluationNovartis
Stephen SquintoChief Investment OfficerJ.P. Morgan Asset Management
R. Scott Struthers, Ph.D.Co-Founder and Chief Executive OfficerCrinetics Pharmaceuticals
Yongkui SunChairman & CEOIONOVA Life Science
Marc Tessier-Lavigne, Ph.D.Co-Founder, Chairman & CEOXaira Therapeutics
Nancy ThornberryFounding CEO & Chair, R&DKallyope
Richard Tillyer, Ph.D.Global Head, Discovery, Product Development & SupplyJohnson & Johnson Innovative Medicine
Matt Tremblay, Ph.D.Chief Executive OfficerBlackbird Laboratories
Issei Tsukamoto, Ph.D.SVP, Head of Business DevelopmentAstellas Pharma
Rupert Vessey, D.Phil.Chief Scientist & Executive PartnerFlagship Pioneering
Scott Wasserman, M.D.Chief Medical OfficerKailera Therapeutics
Jill Wykosky, Ph.D.Venture PartnerRaven (RA Ventures)
Fan Zhang, Ph.D.Vice President of Business DevelopmentBristol Myers Squibb